Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients

Lignende værker

• Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2
  af: Eoh, Kyung Jin, et al.
  Udgivet: (2018)
• Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
  af: Eoh, Kyung Jin, et al.
  Udgivet: (2020)
• Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
  af: Kim, Joo Heung, et al.
  Udgivet: (2021)
• Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
  af: Lee, Yong Jae, et al.
  Udgivet: (2020)
• Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls
  af: Park, Ji Soo, et al.
  Udgivet: (2017)